Topic Code
HORIZON-HLTH-2025-03-ENVHLTH-02-two-stage
F&T Portal
Call Identifier
HORIZON-HLTH-2025-03
Two stage (2025) — Stage 2
Instrument
HORIZON-RIA
Research and Innovation Action
Budget Model
Lump Sum
HORIZON-AG-LS
Funding Rate
100%
Annex G — RIA = 100%
Page Limit (Part B)
45 pages
RIA + lump sum — Stage 2
Evaluation Thresholds
4 / 4 / 4 · cum. 12
Non-standard — Stage 2 override
Expected Projects
5
€7–8M per project (WP stated)
Destination
Living and working in a health-promoting environment
WP Part 4 (2025)
Cluster / Pillar
Cluster 1 / Pillar II
Health
China Eligibility
Eligible ✓
2025 WP: no RIA restriction
Special Conditions
Clustering required
Joint activities WP (~2% budget)
This is a two-stage topic (Stage 2). Stage 1 closed 16 September 2025. Stage 2 deadline: 16 April 2026. Stage 1 page limit: 10 pages. Stage 2 page limit: 45 pages. Blind evaluation pilot applies to Stage 1.
This topic uses non-standard evaluation thresholds: Stage 2: 4 (Excellence) / 4 (Impact) / 4 (Implementation), cumulative 12. Standard thresholds are 3/3/3 cumulative 10.
US entities eligible: In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America are eligible to receive Union funding under this topic.
Copernicus/Galileo: If the project uses satellite-based earth observation, positioning, navigation and/or related timing data, beneficiaries must make use of Copernicus and/or Galileo/EGNOS.
Expected Outcomes
- Environmental and health policies reducing exposure to micro- and nanoplastics and preventing their potential health impacts are supported with up-to-date scientific evidence, standards, tools and methodologies.
- Public authorities and the scientific community have access to FAIR data on realistic human exposures to micro- and nanoplastics and their potential impacts on human health based on real-world scenarios across living and working environments.
- Citizens are informed about the impacts of exposure to micro- and nanoplastics on health and adopt behaviours protecting health and reducing human impacts on the environment.
- Industry is supported in the assessment of products’ safety and sustainability.
- Existing major knowledge gaps in the understanding of the health impacts of exposure to micro- and nanoplastics are filled and mitigation measures based on robust evidence are promoted.
- Public authorities and regulators are supported with evidence-based guidance to design health policies.
Want the full analysis?
The key facts above tell you WHAT. The full Decision Brief tells you HOW to win.
Compliance traps
Scoring playbook
Consortium blueprint
Positioning guide
Red flags
Quick-start checklist
Order Full Brief — €79
Delivered within 1 working day
Disclaimer: This page is produced using advanced AI analysis and reviewed by an experienced EU grant engineer. While we take care to ensure accuracy, the information may contain errors or become outdated. It is the applicant’s sole responsibility to verify all facts against the official
EU Funding & Tenders Portal before making any decisions. Global Disruption accepts no liability for errors, omissions, or decisions made based on this content. No refunds are offered for Key Facts pages or Decision Briefs.